Screening for colorectal cancer in employees of ROSTEСH enterprises in the Sverdlovsk region. Pilot project
https://doi.org/10.33878/2073-7556-2023-22-2-64-69
Abstract
AIM: to evaluate the pilot program results for colorectal cancer (CRC) screening of the Sverdlovsk region (April — October 2021)
PATIENTS AND METHODS: a pilot program of three-stage CRC screening included at the first stage, the fecal immunochemical test was performed (patients aged 45–65 years). The second stage included questionnaire. According to the results of the questioning, patients with a positive fecal test and a potential risk of CRC underwent colonoscopy at the third stage.
RESULTS: at the first and second stages, 969 fecal immunochemical tests and questionnaires were performed. In 149 (15.4%) cases, a positive fecal test was detected. In 22 cases, employees with a negative fecal test were referred for colonoscopy according to the results of the questionnaire. At the third stage, 168 screening colonoscopies were performed. In 87 (51.5%) patients, epithelial colorectal neoplasia was detected, adenoma — in 57 (33.7%) cases, adenocarcinoma in 4 (2.4%), including T0 — in 3 patients, T2 — in 1 patient. In 182 cases, neoplasia occurred in 17.6% in the rectum and in 82.4% in the colon.
CONCLUSION: colorectal cancer (CRC) screening showed high efficacy.
About the Authors
E. N. Desyatov
Sverdlovsk Regional Oncology Center
Russian Federation
Russian Federation
Evgeny N. Desyatov — PhD, head of the endoscopic service
Soboleva str., 29, Yekaterinburg, 620043, Russia
F. Sh. Aliev
Tyumen State Medical University of the Ministry of Health of Russia
Russian Federation
Russian Federation
Fuad Sh. Aliev — Doctor of Medical Sciences, Professor, Honored Doctor of the Russian Federation, Head of the Department of General Surgery
Odesskaya str., 54, Tyumen, 625023, Russia
M. S. Tsvetkov
Sverdlovsk Regional Oncology Center
Russian Federation
Russian Federation
Mikhail S. Tsvetkov — surgeon, endoscopist of the highest qualification category
Soboleva str., 29, Yekaterinburg, 620043, Russia
I. S. Verkhovodova
Sverdlovsk Regional Oncology Center
Russian Federation
Russian Federation
Irina S. Verkhovodova — Head of the department of intraluminal endoscopic diagnostics
Soboleva str., 29, Yekaterinburg, 620043, Russia
I. L. Yakovleva
Sverdlovsk Regional Oncology Center
Russian Federation
Russian Federation
Irina L. Yakovleva — surgeon, endoscopist of the highest qualification category
Soboleva str., 29, Yekaterinburg, 620043, Russia
References
1. Malignant neoplasms in Russia in 2020 (morbidity and mortality) Edited by A.D. Kaprin, V.V. Starinsky, A.O. Shakhzadova. M.: MNIOI im. P.A. Herzen — branch of the Federal State Budgetary Institution “NMITs Radiology” of the Ministry of Health of Russia. 2021; ill., 252 p. (in Russ.).
2. Statistical data of the population of the Sverdlovsk region by sex and age groups as of January 1, 2016–2021 of the Federal State Statistics Service. (in Russ.). https://sverdl.gks.ru/folder/29698
3. Cotton S, Sharp L, Little J. The adenoma-carcinoma sequence and prospects for the prevention of colorectal neoplasia. Crit Rev Oncog. 1996; 7(5-6):293–342. doi: 10.1615/critrevoncog.v7.i5-6.10
4. Crockett SD, Nagtegaal I. Terminology, molecular features, epidemiology, and management of serrated colorectal neoplasia. Gastroenterology. 2019;157:949–66. e4. doi: 10.1053/j.gastro.2019.06.041
5. Zauber AG, Winawer SJ, O’Brien MJ, et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med. 2012;366:687–96. doi: 10.1056/NEJMoa1100370
6. Winawer SJ, Zauber AG, O’Brien MJ, et al. Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. The National Polyp Study Workgroup. N Engl J Med. 1993;328(13):901–6. doi: 10.1056/NEJM199304013281301
7. Martynyuk V.V. Colon cancer (morbidity, mortality, risk factors, screening). Practical oncology. 2000; №1 (March). (in Russ.).
8. Shaukat A, Kahi CJ, Burke CA, et al. Clinical Guidelines: Colorectal Cancer Screening 2021. Am J Gastroenterol. 2021;116:458–479. doi: 10.14309/ajg.0000000000001122
9. Woodall M, DeLetter M. Colorectal Cancer. A collaborative approach to improve education and screening in a rural population. Clinical Journal of Oncology Nursing. 2017;22(14):69–75. doi: 10.1188/18.cjon.69-75
10. Lin JS, Piper MA, Perdue LA, et al. Screening for colorectal cancer: Updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2016;315:2576–94. doi: 10.1001/jama.2016.3332
11. Knudsen AB, Hur C, Gazelle GS, et al. Rescreening of persons with a negative colonoscopy result: Results from a microsimulation model. Ann Intern Med. 2012;157:611–20. doi: 10.7326/0003-4819-157-9-201211060-00005
12. Rex DK, Petrini JL, Baron TH, et al. Quality indicators for colonoscopy. Gastrointest Endosc. 2006;63:S16–28. doi: 10.1016/j.gie.2006.02.021
13. Hoff G, Holme O, Bretthauer M, et al. Cecum intubation rate as quality indicator in clinical versus screening colonoscopy. Endosc Int Open. 2017;5(6):E489–95. doi: 10.1055/s-0043-106180
14. Barclay RL, Vicari JJ, Doughty AS, et al. Colonoscopic withdrawal times and adenoma detection during screening colonoscopy. N Eng J Med. 2006;355(24):2533–41. doi: 10.1056/NEJMoa055498
15. Millan MS, Gross P, Manilich E, Church JM. Adenoma detection rate: the real indicator of quality in colonoscopy. Dis Colon Rectum. 2008;51(8):1217–20. doi: 10.1007/s10350-008-9315-3
Review
For citations:
Desyatov E.N., Aliev F.Sh., Tsvetkov M.S., Verkhovodova I.S., Yakovleva I.L. Screening for colorectal cancer in employees of ROSTEСH enterprises in the Sverdlovsk region. Pilot project. Koloproktologia. 2023;22(2):64-69. https://doi.org/10.33878/2073-7556-2023-22-2-64-69
Views:
410
Email this article 
